MDGL icon

Madrigal Pharmaceuticals
MDGL

Overview Fund Activity

31 hedge funds and large institutions have $12.8M invested in Madrigal Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 28 reducing their positions, and 26 closing their positions.

Holders
31
Holders Change
-24
Holders Change %
-43.64%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
–
Reduced
28
Closed
26
Calls
$26K
Puts
$63K
Net Calls
-$37K
Net Calls Change
-$55K

Top Buyers

1
AC
1
Armistice Capital
New York
$1.67M
2
RSCM
2
Rock Springs Capital Management
Maryland
$799K
3
Goldman Sachs
3
Goldman Sachs
New York
$153K
4
PAM
4
Panagora Asset Management
Massachusetts
$42K
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$1K

Top Sellers

1
CC
1
Caxton Corporation
New Jersey
$6.43M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.29M
3
Connor, Clark & Lunn Investment Management (CC&L)
3
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$0
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$0
5
Millennium Management
5
Millennium Management
New York
$205K
Name Market Value Shares Shares
Change 		Shares
Change %
Barclays
51
Barclays
United Kingdom
$0 4 -367 -99%
Citigroup
52
Citigroup
New York
– – -99 Closed
PNC Financial Services Group
53
PNC Financial Services Group
Pennsylvania
– – -73 Closed
AIM
54
Advantage Investment Management
Iowa
– – -43 Closed
First Manhattan
55
First Manhattan
New York
– – -3 Closed
Manulife (Manufacturers Life Insurance)
56
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$0 29 – –
DekaBank Deutsche Girozentrale
57
DekaBank Deutsche Girozentrale
Germany
$0 4 +1 +33%
1 2
3